Bronchogen

Source / Derivation:

Bronchogen is a synthetic peptide developed to support respiratory health and pulmonary tissue function. It is based on naturally occurring peptides involved in airway repair and immune defense. Bronchogen has been studied for its potential to enhance lung resilience and recovery in preclinical and clinical models.

Bronchogen

Mechanism of Action:

Bronchogen modulates immune responses within pulmonary tissues, supports epithelial repair, and reduces inflammation in the airways. It also promotes cellular recovery and mucosal integrity. Additionally, Bronchogen may enhance pulmonary defense mechanisms and improve overall respiratory function.

Clinical Relevance & Potential Outcomes:

Research suggests Bronchogen may support improved lung tissue repair, enhanced immune defense in the respiratory tract, and reduced airway inflammation. It has potential applications in chronic respiratory conditions, recovery from lung injury, and supportive pulmonary care. Clinical studies indicate it may contribute to improved lung function and resilience.

Intended Clinical Application:

Bronchogen may be relevant for patients requiring pulmonary support, enhanced airway repair, or immune modulation in the respiratory tract. It may also be considered for adjunctive therapy in chronic or acute respiratory conditions.

Formulation & Quality Specifications:

Delivered as a liquid prefilled pen
Purity: >98% (HPLC-validated)
Storage: 2–8 °C (refrigerated)
Documentation: Full CoA and MSDS available

Concentration:

Frequency:

Dosage (pen clicks):

Duration:

Notes:

10 mg/ml, total 3 ml, total 30 mg

Daily

1 month

Bronchogen is typically used for lung and respiratory support and is cycled with breaks for optimal results.

Learn More